CURREN FOUNDATION FOR THE DIAGNOSIS & TREATMENT OF NEURO-ONCOLOGICAL (EIN 831625577) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2018

Principal Officer

HARLEY E RIEDEL II

Tax Period

2020-01-01 to 2020-12-31

CURREN FOUNDATION FOR THE DIAGNOSIS & TREATMENT OF NEURO-ONCOLOGICAL, founded in 2018, is a small nonprofit in the Health Care sector that reported $107K in total revenue in fiscal year 2020. Expenses of $119K exceeded revenue, resulting in a 11% operating deficit.

Mission

THE PRIMARY PURPOSES OF THE FOUNDATION ARE TO PROMOTE THE EARLY DIAGNOSIS OF PARANEOPLASTIC SYNDROME (PNS) LEADING TO CEREBELLAR DEGENERATION AND TO ASSIST VICTIMS OF THE DISEASE, THEIR FAMILIES, MEDICAL PROVIDERS, AND CAREGIVERS WHILE THEY ARE UNDERGOING TREATMENT.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2020)

Revenue Breakdown

Contributions & Grants $107,032

Program Service Revenue $0

Investment Income $392

Other Revenue $0

TOTAL REVENUE $107,424

Expense Breakdown

Grants Paid $0

Salaries & Benefits $114,739

Fundraising Expenses $0

Program Expenses $117,062

Other Expenses $4,656

TOTAL EXPENSES $119,395

Year-over-Year Comparison

	2020	2019	Change
Revenue	$107,424	N/A	N/A
Expenses	$119,395	N/A	N/A
Net Income	$-11,971	N/A	N/A

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
HARLEY E RIEDEL II	PRESIDENT	2.00	Officer	$0	$0	$0
ASHLIE R TEELING	TREASURER	2.00	Officer	$0	$0	$0
JOHN T PINKARD	SECRETARY	0.50	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2020	$107,424	$119,395	$71,031	$-11,971

CURREN FOUNDATION FOR THE DIAGNOSIS & TREATMENT OF NEURO-ONCOLOGICAL